Inner Mongolia Furui Medical Science Co., Ltd.

SZSE:300049 Stock Report

Market Cap: CN¥14.2b

Inner Mongolia Furui Medical Science Future Growth

Future criteria checks 5/6

Inner Mongolia Furui Medical Science is forecast to grow earnings and revenue by 40.5% and 28.9% per annum respectively. EPS is expected to grow by 40.3% per annum. Return on equity is forecast to be 17.5% in 3 years.

Key information

40.5%

Earnings growth rate

40.3%

EPS growth rate

Pharmaceuticals earnings growth18.0%
Revenue growth rate28.9%
Future return on equity17.5%
Analyst coverage

Low

Last updated20 May 2024

Recent future growth updates

Recent updates

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

May 24
With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Apr 29
We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Feb 28
Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Earnings and Revenue Growth Forecasts

SZSE:300049 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,7714303126333
12/31/20252,1593071104534
12/31/20241,584203-102154
3/31/20241,23413190273N/A
12/31/20231,154102116305N/A
9/30/20231,09711099282N/A
6/30/20231,084109148268N/A
3/31/20231,042102109223N/A
1/1/20231,0099899189N/A
9/30/20221,01798120197N/A
6/30/20229608690174N/A
3/31/202293192134221N/A
1/1/202289895143223N/A
9/30/202184890125220N/A
6/30/20218328983201N/A
3/31/20217806460169N/A
12/31/20208086290200N/A
9/30/20208175079171N/A
6/30/202080842144210N/A
3/31/202086247213278N/A
12/31/201983243190256N/A
9/30/20198581176269N/A
6/30/2019865393178N/A
3/31/20198663224122N/A
12/31/201886735-1678N/A
9/30/2018824712384N/A
6/30/20187997080138N/A
3/31/20188446392138N/A
12/31/201782361N/A132N/A
9/30/2017882117N/A106N/A
6/30/2017886117N/A109N/A
3/31/2017858121N/A114N/A
12/31/2016827121N/A149N/A
9/30/2016709100N/A189N/A
6/30/201667199N/A143N/A
3/31/201660892N/A167N/A
12/31/201560492N/A158N/A
9/30/201564990N/A101N/A
6/30/2015668108N/A127N/A
3/31/201563490N/A72N/A
12/31/201464687N/A51N/A
9/30/201456739N/A23N/A
6/30/201456415N/A36N/A
3/31/20145337N/A27N/A
12/31/20135235N/A28N/A
9/30/20135166N/A25N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300049's forecast earnings growth (40.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 300049's earnings (40.5% per year) are forecast to grow faster than the CN market (22.2% per year).

High Growth Earnings: 300049's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300049's revenue (28.9% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 300049's revenue (28.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 300049's Return on Equity is forecast to be low in 3 years time (17.5%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.